Teriflunomide (Aubagio) 14mg once daily tablet

Size: px
Start display at page:

Download "Teriflunomide (Aubagio) 14mg once daily tablet"

Transcription

1 Teriflunomide (Aubagio) 14mg once daily tablet Exceptional healthcare, personally delivered

2 Your Consultant Neurologist has suggested that you may benefit from treatment with Teriflunomide. The decision to start this form of treatment can be difficult. Therefore, this leaflet gives you some information about Teriflunomide. Your Consultant Neurologist, Speciality Doctor or MS Specialist Nurse may be able to answer any further questions you may have. What is Teriflunomide? Teriflunomide is a tablet which is given to try and reduce the frequency of MS relapses. We hope that this may reduce the chance of accumulating disability over time (years). However, although clinical trials have shown Teriflunomide reduces relapse rates, it is still unknown as to whether or not it will make a significant impact on your level of disability over the long term. Normally our immune system defends our bodies against infection. In MS is it believed that the immune system mistakenly identifies the body s nerve tissue in the brain and spinal cord as a foreign intruder and attacks it. This causes damage to the protective coating (called myelin), which surrounds the nerves and can lead to scarring (sclerosis) of the tissue. This causes disruption of the messages that are sent via the brain and spinal cord and can cause a variety of symptoms. Teriflunomide helps to protect against attacks on the central nervous system by the immune system by limiting the increase of some white blood cells (Lymphocytes). This limits the inflammation that leads to nerve damage in MS. How is Teriflunomide taken? Teriflunomide is a once daily, oral tablet which can be taken at any time of the day, though we would recommend that it is taken at roughly the same time each day. It can be taken with or without food. 2 Teriflunomide (Aubagio) 14mg once daily tablet

3 Things your Consultant needs to know Medications Before starting any new medication it is important that you inform your consultant of all the medication you are taking, both prescribed and bought over the counter. This will include any recreational medications. This is so your consultant can ensure that your medication does not interact with Teriflunomide. If you do begin taking Teriflunomide you should also check with your GP, MS team or pharmacist for interactions with any new medication you are prescribed before taking it. In addition other immunosuppressant or immunomodulating medications should be avoided. Infection It is important to inform your Consultant if you have any infections. We will be required to check your blood prior to initiating treatment this is to ensure you have enough white blood cells and platelets prior to starting Teriflunomide. This is because Teriflunomide decreases the number of white cells in the blood which may lead to difficulty fighting infection. It may be necessary to delay/stop treatment until the infection has resolved. Other Health ProblemsPrior to starting treatment your consultant will wish to ensure the drug is suitable for you. You will need to inform your consultant of any other health conditions you may have or have had previously. In particular it is important to inform your specialist if you have or are suffering from liver disease. Teriflunomide (Aubagio) 14mg once daily tablet 3

4 Pregnancy or breast feeding It is very important that you do not take Teriflunomide if you are trying to conceive, pregnant, or think you may be pregnant. If you are pregnant or become pregnant whilst taking Teriflunomide, the risk of having a baby with birth defects is believed to be increased. Therefore if you suspect you are pregnant whilst taking Teriflunomide or in the two years after you have stopped treatment, you must contact your doctor immediately. It is also important to tell your doctor if you plan to become pregnant after stopping treatment. It can take a long time for the effects of Teriflunomide to be naturally removed from your body. It is therefore advised that woman should not try to conceive for TWO years after stopping Teriflunomide. However there are medications that can be given once Teriflunomide is stopped that accelerate the removal of this medication allowing safe pregnancy earlier. Blood tests will need to be performed after such accelerated elimination. Do not take Teriflunomide if you are breast feeding, as Teriflunomide passes on through the breast milk. Contraception Woman of childbearing potential must use an effective method of contraception during two years after stopping treatment with Teriflunomide. Talk to your GP about the best methods of contraception for you. The effects of teriflunomide on male fertility continue to be evaluated but, to date, there is no evidence to restrict its use in men who wish to father a child. Lactose Teriflunomide contains lactose. If you think you maybe intolerant to some sugars please discuss this with your GP prior to taking this medication. 4 Teriflunomide (Aubagio) 14mg once daily tablet

5 What tests will I need before I can start Teriflunomide? Prior to starting Teriflunomide we will need to perform some tests. These will include: n Blood and urine test including a pregnancy test (if applicable) n A recording of your blood pressure What test will need to be done once I commence Teriflunomide? You will be required to attend a health facility for monitoring of your blood every 2 weeks for the first 6 months and every 8 weeks thereafter. It is very important to attend these appointments, failing to do so could cause you harm and may result in our being able to continue your prescriptions. You blood pressure will be monitored at regular intervals whilst you are on treatment. Possible side effects Like all medicines, this medicine can cause side effects, although according to large trials with MS patients these appear to be largely infrequent. The following side effects may happen with this medicine. Serious side effects Tell your GP or MS Nurse straight away, if you notice any of the following serious side effects: n Jaundice, yellowing of your skin or the whites of your eyes, darker urine than normal or unexplained nausea and vomiting - these may be signs of a liver problem and you will need to have a blood test. Teriflunomide (Aubagio) 14mg once daily tablet 5

6 n Infection this may include flu (fever or flu like symptoms); sinus or throat infection; urinary tract infection or cystitis; bronchitis; diarrhoea or being sick; cold sores; tooth infection; laryngitis or fungal foot infection. Other side effects include: Very common side effects (may effect more than 1 in 10 people): n Upper respiratory tract infection, urinary tract infection n Pins and needles n Diarrhoea, feeling sick n Increase in ALT ( increase in blood levels of certain liver enzymes) shown in your regular blood tests. This typically reverses when the drug is stopped. n Hair thinning, this is reported as being transient and usually occurs within the first six months. Common side effects (may effect up to 1 in 10 people): n Bronchitis, sinusitis, sore throat and discomfort when swallowing, cystitis, gastroenteritis viral, oral herpes, tooth infection, laryngitis, fungal infection of the foot n Low levels of white blood cells shown in your regular blood tests n Mild allergic reaction n Feeling anxious n Feeling weak, numb, tingling or pain in the lower back or leg (sciatica); feeling numb, burning, tingling or pain in the hands and fingers, increased feeling of sensitivity, especially in the skin; stabbing or throbbing pain along one or more nerves. 6 Teriflunomide (Aubagio) 14mg once daily tablet

7 n Increase in blood pressure, this is usually mild. n Vomiting n Toothache n Rash, acne n Pain of the tendons, joints, bones, muscle pain n Needing to urinate more often than usual n Heavy periods n Pain n Changes in liver and white cell test n Weight loss Uncommon side effects (may effect up to 1 in 100): n Decrease in the number of red cells (anaemia) and a decrease in the number of blood platelets (thrombocytopenia) n Peripheral Neuropathy. In placebo controlled trials peripheral nerve damage including carpal tunnel syndrome was seen more commonly in patients taking Teriflunomide than those taking placebo. The symptoms of peripheral nerve damage can sometimes be difficult to determine from MS symptoms. Very rare side effects (may effect up to 1 in 10,000 people) n Inflammation of the lung (interstitial lung disease) n Inflammation of the pancreas (pancreatitis) Teriflunomide (Aubagio) 14mg once daily tablet 7

8 Can this medication cause Cancer? There does not appear to be an increased risk of malignancy with Teriflunomide within the clinical trials. The risk of cancer, particularly cancer of the white blood cells, is increased with use of some other agents that affect the immune system (class effect). What happens next? If you and your consultant decide this is the right treatment for you, an appointment may be arranged for you to attend your MS Outpatient Clinic for baseline assessments and bloods. Providing all your assessments are within normal limits we will proceed with requesting your prescription. The medication will be delivered to your nominated delivery address after a prescription is issued by your MS doctor. It is very important that you read the product information provided with the medication. It is also very important that you remember to take this medication on a regular basis and do not accidently take more than one dose within 24 hours. It will be your or your carer s responsibility to ensure that you have the recommended blood tests after starting Teriflunomide. These should ideally be carried out at your GP surgery. However if this is not possible the MS team can try to help. Alternative medications Currently there are other therapies recommended for the treatment of relapses however these will be offered to you if appropriate by your Consultant. 8 Teriflunomide (Aubagio) 14mg once daily tablet

9 Frequently asked Questions Can I go abroad? Yes. You can continue your medication as normal. Check with your airline first to ensure a letter to travel with medication is not needed. What if I need vaccinations? Always check with your GP, Consultant or MS Specialist nurse before you have any vaccinations. Live vaccinations may carry the risk of infection and should therefore be avoided. Can I drink alcohol? There is no firm evidence to suggest that alcohol should be avoided however please drink responsibly in accordance with government guidelines. What if I miss a dose? If you forget a dose one day, do not take two doses at the same time. Continue to take the next dose as you normally would. Do not stop Teriflunomide without talking to your consultant first. Can I still have Steroids whilst taking Teriflunomide? Yes if necessary. Your Consultant or GP will advise on the use of steroids if they are required. Can I drive? Teriflunomide may cause you to feel dizzy, which will possibly impair your ability to concentrate and react. If you are affected by this you should not drive or use any machinery. Teriflunomide (Aubagio) 14mg once daily tablet 9

10 Do I need to inform other health care professionals that I am taking this drug? Yes. We will let your GP know, but other health care professionals such as other GPs or your Dentist may want to prescribe you new medication. Please always inform your GP / dentist or other prescribing doctor that you are taking Teriflunomide when new medications are suggested. What shall I do if I wish to become pregnant? If you are considering starting a family in the near future you MUST discuss your plans with a health care professional prior to stopping medication and contraception. 10 Teriflunomide (Aubagio) 14mg once daily tablet

11 More information You can find further information and support from the following organisations: Multiple Sclerosis Trust Multiple Sclerosis Society NICE References: Summary of product characteristics, 2013, Sanofi-aventis groupe: Paris Information for the patient, 2013, Sanofi-aventis groupe: Paris National Institute for Health and Excellence (Nice) Teriflunomide for treating relapsing-remitting multiple sclerosis, 2014, Nice: London NHS Constitution. Information on your rights and responsibilities. Available at Teriflunomide (Aubagio) 14mg once daily tablet 11

12 If you or the individual you are caring for need support reading this leaflet please ask a member of staff for advice. North Bristol NHS Trust. This edition published May Review due May NBT002842

Gilenya. Exceptional healthcare, personally delivered

Gilenya. Exceptional healthcare, personally delivered Gilenya Exceptional healthcare, personally delivered Your Consultant Neurologist has suggested that you may benefit from treatment with Gilenya. The decision to start this form of treatment can be difficult.

More information

AUBAGIO Conversation Starter

AUBAGIO Conversation Starter AUBAGIO Conversation Starter When you are choosing a multiple sclerosis (MS) treatment for the first time or are considering switching your MS therapy, there can be a lot to think about for both you and

More information

MS Treatments Aubagio TM

MS Treatments Aubagio TM 1 MSology Essentials Series Aubagio TM (teriflunomide) Developed by MSology with the invaluable assistance of multiple sclerosis nurse advisors: Bonnie Blain Central Alberta MS Clinic, Red Deer, Alberta

More information

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been

More information

Intravenous Methyl Prednisolone in Multiple Sclerosis

Intravenous Methyl Prednisolone in Multiple Sclerosis Intravenous Methyl Prednisolone in Multiple Sclerosis Exceptional healthcare, personally delivered Relapse management in multiple sclerosis Relapses in multiple sclerosis (MS) are common and caused by

More information

Multiple sclerosis disease-modifying drugs second line treatments

Multiple sclerosis disease-modifying drugs second line treatments Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Multiple sclerosis disease-modifying drugs second line treatments The following information should be read in conjunction

More information

Leflunomide Leflunomide

Leflunomide Leflunomide Drug information Leflunomide Leflunomide This leaflet provides information on leflunomide and will answer any questions you have about the treatment. Arthritis Research UK produce and print our booklets

More information

Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients

Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients Oxford University Hospitals NHS Trust Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis Information for patients page 2 What is Natalizumab and what is it used for? Natalizumab is an

More information

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets

MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets MEDICATION GUIDE KOMBIGLYZE XR (kom-be-glyze X-R) (saxagliptin and metformin HCl extended-release) tablets Read this Medication Guide carefully before you start taking KOMBIGLYZE XR and each time you get

More information

Understanding your Tecfidera treatment

Understanding your Tecfidera treatment Understanding your Tecfidera treatment Information for patients who have been prescribed treatment with Tecfidera. (dimethyl fumarate) Contents About Multiple Sclerosis (MS) What is MS? Symptoms of MS

More information

Understanding your Tecfidera treatment

Understanding your Tecfidera treatment Understanding your Tecfidera treatment Information for patients who have been prescribed treatment with Tecfidera. (dimethyl fumarate) Contents About Multiple Sclerosis (MS) What is MS? Symptoms of MS

More information

A guide to the accelerated elimination procedure

A guide to the accelerated elimination procedure A guide to the accelerated elimination procedure Prescribing information and information on adverse event reporting can be found on the last page. What is the accelerated elimination procedure? An accelerated

More information

Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules

Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules Medication Guide TASIGNA (ta-sig-na) (nilotinib) Capsules Read this Medication Guide before you start taking Tasigna and each time you get a refill. There may be new information. This information does

More information

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST?

MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules. What is the most important information I should know about POMALYST? MEDICATION GUIDE POMALYST (POM-uh-list) (pomalidomide) capsules What is the most important information I should know about POMALYST? Before you begin taking POMALYST, you must read and agree to all of

More information

MS Treatments Gilenya

MS Treatments Gilenya 1 MSology Essentials Series Gilenya (fingolimod) Developed by MSology with the invaluable assistance of multiple sclerosis nurse advisors: Trudy Campbell Dalhousie MS Research Unit, Capital Health, Halifax,

More information

MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate

MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate Read this Medication Guide before you start receiving mitoxantrone and each time you receive mitoxantrone. There may be new information.

More information

Long term observational study for multiple sclerosis patients using fingolimod

Long term observational study for multiple sclerosis patients using fingolimod Investigator: Dr Matthew Jackson (Consultant Neurologist) Centre number: 814 Contact for queries If you have any questions about this study, you can contact: Daytime: Elspeth Wolfenden on 01494 734312

More information

Patient Medication Guide Brochure

Patient Medication Guide Brochure Patient Medication Guide Brochure 1 MEDICATION GUIDE TASIGNA (ta-sig-na) (nilotinib) Capsules Read this Medication Guide before you start taking TASIGNA and each time you get a refill. There may be new

More information

JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets

JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets JANUVIA sitagliptin phosphate 25 mg, 50 mg & 100 mg tablets What is in this leaflet This leaflet answers some common questions about JANUVIA. It does not contain all the available information. It does

More information

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide For Patients What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide Patients: Your doctor or nurse will go over this patient guide with you. It is important to ask any questions

More information

Optic Neuritis. The optic nerve fibers are coated with myelin to help them conduct the electrical signals back to your brain.

Optic Neuritis. The optic nerve fibers are coated with myelin to help them conduct the electrical signals back to your brain. Optic Neuritis Your doctor thinks that you have had an episode of optic neuritis. This is the most common cause of sudden visual loss in a young patient. It is often associated with discomfort in or around

More information

A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT

A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk

More information

LEFLUNOMIDE (Adults)

LEFLUNOMIDE (Adults) Shared Care Guideline DRUG: Introduction: LEFLUNOMIDE (Adults) Indication: Disease modifying drug for rheumatoid arthritis and psoriatic arthritis Licensing Information: Disease modifying drug for active

More information

Temozolomide (oral) with concurrent radiotherapy to the brain

Temozolomide (oral) with concurrent radiotherapy to the brain Temozolomide (oral) with concurrent radiotherapy to the brain Temozolomide (oral) with concurrent radiotherapy to the brain This leaflet is offered as a guide to you and your family. You will find it useful

More information

IF YOU ARE RECEIVING TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS (NATALIZUMAB)

IF YOU ARE RECEIVING TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS (NATALIZUMAB) IF YOU ARE RECEIVING (NATALIZUMAB) TREATMENT WITH TYSABRI FOR RELAPSING-REMITTING MS Read the patient information leaflet that accompanies the medicine carefully. 1 This brochure is a supplement to the

More information

Vincristine by short infusion Doxorubicin by injection Cyclophosphamide by injection Rituximab by an infusion over between 60 minutes to a few hours

Vincristine by short infusion Doxorubicin by injection Cyclophosphamide by injection Rituximab by an infusion over between 60 minutes to a few hours R-CHOP R-CHOP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others

More information

Paracetamol apollo +9191 46 950 950. Paracetamol apollo +9191 46 950 950. Paracetamol

Paracetamol apollo +9191 46 950 950. Paracetamol apollo +9191 46 950 950. Paracetamol Paracetamol apollo +9191 46 950 950 Paracetamol apollo +9191 46 950 950 Paracetamol CAS Number : 103-90-2 Molecular Weight : 151.17 g/mol Molecular Formula : C8H9NO2 Systematic (IUPAC) : N-(4- hydroxyphenyl)ethanamide

More information

Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults

Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: Your doctor* said you have alcohol use disorder

More information

Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU

Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU FOR MS RELAPSES Stepping toward a different treatment option LEARN WHAT ACTHAR CAN DO FOR YOU As a person with multiple sclerosis (MS), you know firsthand the profound impact MS relapses can have on your

More information

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR ATRIAL FIBRILLATION

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR ATRIAL FIBRILLATION ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR ATRIAL FIBRILLATION Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet has

More information

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets

MEDICATION GUIDE ACTOPLUS MET (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets MEDICATION GUIDE (ak-tō-plus-met) (pioglitazone hydrochloride and metformin hydrochloride) tablets Read this Medication Guide carefully before you start taking and each time you get a refill. There may

More information

Which injectable medication should I take for relapsing-remitting multiple sclerosis?

Which injectable medication should I take for relapsing-remitting multiple sclerosis? Which injectable medication should I take for relapsing-remitting multiple sclerosis? A decision aid to discuss options with your doctor This decision aid is for you if you: Have multiple sclerosis Have

More information

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE)

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE) ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet has

More information

Bone Marrow or Blood Stem Cell Transplants in Children With Severe Forms of Autoimmune Disorders or Certain Types of Cancer

Bone Marrow or Blood Stem Cell Transplants in Children With Severe Forms of Autoimmune Disorders or Certain Types of Cancer Bone Marrow or Blood Stem Cell Transplants in Children With Severe Forms of Autoimmune Disorders or Certain Types of Cancer A Review of the Research for Parents and Caregivers Is This Information Right

More information

Share the important information in this Medication Guide with members of your household.

Share the important information in this Medication Guide with members of your household. MEDICATION GUIDE BUPRENORPHINE (BUE-pre-NOR-feen) Sublingual Tablets, CIII IMPORTANT: Keep buprenorphine sublingual tablets in a secure place away from children. Accidental use by a child is a medical

More information

Teriflunomide (Aubagio)

Teriflunomide (Aubagio) Teriflunomide (Aubagio) Spirella Building, Letchworth, SG6 4ET 01462 476700 www.mstrust.org.uk reg charity no. 1088353 We hope you find the information in this factsheet helpful. If you would like to speak

More information

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT) ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FEC-T. Patient s first names. Date of birth.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FEC-T. Patient s first names. Date of birth. Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FEC-T Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas

More information

THE 7:16 WAS ON TIME BUT MY LEGS WERE BEHIND SCHEDULE THAT S WHEN I ASKED FOR THE WALKING PILL

THE 7:16 WAS ON TIME BUT MY LEGS WERE BEHIND SCHEDULE THAT S WHEN I ASKED FOR THE WALKING PILL THE 7:16 WAS ON TIME BUT MY LEGS WERE BEHIND SCHEDULE THAT S WHEN I ASKED FOR THE WALKING PILL See page 12 for FREE* TRIAL OFFER *Limitations and restrictions apply. Actor portrayal AMPYRA (dalfampridine)

More information

Treating Chronic Hepatitis C. A Review of the Research for Adults

Treating Chronic Hepatitis C. A Review of the Research for Adults Treating Chronic Hepatitis C A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: Your doctor* has told you that you have chronic hepatitis C.

More information

Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families

Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families Eastern Health MS Service Tysabri Therapy Information for People with MS and their Families The Eastern Health MS Service has developed this information for you as a guide through what will happen to you

More information

MEDICATION GUIDE. These serious side effects are described below:

MEDICATION GUIDE. These serious side effects are described below: MEDICATION GUIDE LYRICA (LEER-i-kah) (pregabalin) Capsules and Oral Solution, CV Read this Medication Guide before you start taking LYRICA and each time you get a refill. There may be new information.

More information

MEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) Read the Medication Guide that comes with REMICADE before you receive the first treatment, and

MEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) Read the Medication Guide that comes with REMICADE before you receive the first treatment, and MEDICATION GUIDE REMICADE (Rem-eh-kaid) (infliximab) Read the Medication Guide that comes with REMICADE before you receive the first treatment, and before each time you get a treatment of REMICADE. This

More information

Bone Marrow or Blood Stem Cell Transplants in Children With Certain Rare Inherited Metabolic Diseases *

Bone Marrow or Blood Stem Cell Transplants in Children With Certain Rare Inherited Metabolic Diseases * Bone Marrow or Blood Stem Cell Transplants in Children With Certain Rare Inherited Metabolic Diseases * A Review of the Research for Parents and Caregivers * Wolman Disease, Farber Disease, Niemann-Pick

More information

Patient Guide. Important information for patients starting therapy with LEMTRADA (alemtuzumab)

Patient Guide. Important information for patients starting therapy with LEMTRADA (alemtuzumab) Patient Guide Important information for patients starting therapy with LEMTRADA (alemtuzumab) This medicinal product is subject to additional monitoring. This will allow quick identification of new safety

More information

Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets

Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets Read this Patient Information carefully before you start taking VYTORIN and each time you get a refill. There may be new information.

More information

Methotrexate treatment

Methotrexate treatment Methotrexate treatment Oral methotrexate pre-treatment patient information leaflet This leaflet has been prepared to support information given to you as part of your discussions with the doctor, nurse

More information

Rituximab. Drug information Rituximab. This leaflet provides information on rituximab and will answer any questions you have about the treatment.

Rituximab. Drug information Rituximab. This leaflet provides information on rituximab and will answer any questions you have about the treatment. Drug information Rituximab Rituximab This leaflet provides information on rituximab and will answer any questions you have about the treatment. Arthritis Research UK produce and print our booklets entirely

More information

METHOTREXATE TREATMENT

METHOTREXATE TREATMENT METHOTREXATE TREATMENT This leaflet has been prepared to support information given to you as part of your discussions with the doctor, nurse or pharmacist before you start treatment with oral methotrexate.

More information

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:

Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider: Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP Primary Care Provider: If you are considering hepatitis C treatment, please read this treatment

More information

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital

Mitoxantrone. For multiple sclerosis. InfoNEURO INFORMATION FOR PATIENTS. Montreal Neurological Hospital i InfoNEURO Montreal Neurological Hospital INFORMATION FOR PATIENTS Mitoxantrone For multiple sclerosis Centre universitaire de santé McGill McGill University Health Centre Collaborators: D. Lowden Clinical

More information

MEDICATION GUIDE COUMADIN (COU-ma-din) (warfarin sodium)

MEDICATION GUIDE COUMADIN (COU-ma-din) (warfarin sodium) MEDICATION GUIDE COUMADIN (COU-ma-din) (warfarin sodium) Read this Medication Guide before you start taking COUMADIN (warfarin sodium) and each time you get a refill. There may be new information. This

More information

Patient Information Leaflet

Patient Information Leaflet Patient Information Leaflet METHOTREXATE We hope this fact sheet will provide you with some information about Methotrexate and answer some of the questions you may have. Methotrexate is available in tablet

More information

MEDICATION GUIDE. ACTEMRA (AC-TEM-RA) (tocilizumab) Solution for Intravenous Infusion

MEDICATION GUIDE. ACTEMRA (AC-TEM-RA) (tocilizumab) Solution for Intravenous Infusion MEDICATION GUIDE ACTEMRA (AC-TEM-RA) (tocilizumab) Solution for Intravenous Infusion ACTEMRA (AC-TEM-RA) (tocilizumab) Injection, Solution for Subcutaneous Administration Read this Medication Guide before

More information

National Hospital for Neurology and Neurosurgery. Managing Spasticity. Spasticity Service

National Hospital for Neurology and Neurosurgery. Managing Spasticity. Spasticity Service National Hospital for Neurology and Neurosurgery Managing Spasticity Spasticity Service If you would like this document in another language or format, or require the services of an interpreter please contact

More information

Chemotherapy for lung cancer

Chemotherapy for lung cancer This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 8. Contents Chemoradiation Small cell lung cancer

More information

Your patient-held blood monitoring record book. Disease-modifying treatment for multiple sclerosis (MS)

Your patient-held blood monitoring record book. Disease-modifying treatment for multiple sclerosis (MS) Your patient-held blood monitoring record book Disease-modifying treatment for multiple sclerosis (MS) Your details Your current therapy: Name: Date of birth: Hospital/clinic: Hospital number: NHS number:

More information

Gemcitabine and Cisplatin

Gemcitabine and Cisplatin PATIENT EDUCATION patienteducation.osumc.edu What is Gemcitabine (jem-site-a been)? Gemcitabine is a chemotherapy medicine known as an anti-metabolite. Another name for this drug is Gemzar. This drug is

More information

Disease Modifying Therapies for MS

Disease Modifying Therapies for MS Disease Modifying Therapies for MS The term disease-modifying therapy (DMT) means a drug that can modify or change the course of a disease. In other words a DMT should be able to reduce the number of attacks

More information

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN PATIENT INFORMATION LEAFLET CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again.

More information

Tuberculosis and You A Guide to Tuberculosis Treatment and Services

Tuberculosis and You A Guide to Tuberculosis Treatment and Services Tuberculosis and You A Guide to Tuberculosis Treatment and Services Tuberculosis (TB) is a serious disease that can damage the lungs or other parts of the body like the brain, kidneys or spine. There are

More information

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients

VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients VAD Chemotherapy Regimen for Multiple Myeloma Information for Patients The Regimen contains: V = vincristine (Oncovin ) A = Adriamycin (doxorubicin) D = Decadron (dexamethasone) How Is This Regimen Given?

More information

5.07.09. Aubagio. Aubagio (teriflunomide) Description

5.07.09. Aubagio. Aubagio (teriflunomide) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.07.09 Subject: Aubagio Page: 1 of 6 Last Review Date: December 5, 2014 Aubagio Description Aubagio (teriflunomide)

More information

Atrial Fibrillation and Anticoagulants

Atrial Fibrillation and Anticoagulants York Teaching Hospital NHS Foundation Trust Atrial Fibrillation and Anticoagulants A guide to your diagnosis and treatment Information for patients, relatives and carers For more information, please contact:

More information

Use of oral steroids in Multiple Sclerosis

Use of oral steroids in Multiple Sclerosis Use of oral steroids in Multiple Sclerosis Information for patients and carers Neurology Department Aberdeen Royal Infirmary What are steroids? The steroids used to treat Multiple Sclerosis (MS) relapses

More information

Disease Modifying Therapies for MS

Disease Modifying Therapies for MS Disease Modifying Therapies for MS The term disease-modifying therapy means a drug that can modify or change the course of a disease. In other words a DMT should be able to reduce the number of attacks

More information

Allopurinol Allopurinol

Allopurinol Allopurinol Drug information Allopurinol Allopurinol This leaflet provides information on allopurinol and will answer any questions you have about the treatment. Arthritis Research UK produce and print our booklets

More information

CVP Chemotherapy Regimen for Lymphoma Information for Patients

CVP Chemotherapy Regimen for Lymphoma Information for Patients CVP Chemotherapy Regimen for Lymphoma Information for Patients The Regimen Contains: C: Cyclophosphamide (Cytoxan ) V: Vincristine (Oncovin ) P: Prednisone How Is This Regimen Given? CVP is given every

More information

BE SURE. BE SAFE. VACCINATE.

BE SURE. BE SAFE. VACCINATE. DON T GET OR GIVE THE FLU THIS YEAR THANK YOU Vaccination is the only protection. www.immunisation.ie BE SURE. BE SAFE. VACCINATE. FLU VACCINE 2013-2014 Healthcare workers prevent the spread of flu and

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride)

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride) PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride) This medicine is for use in men only Read all of this leaflet carefully before you start to take this medicine.

More information

INFUSE Bone Graft (rhbmp-2/acs)

INFUSE Bone Graft (rhbmp-2/acs) 1 INFUSE Bone Graft (rhbmp-2/acs) For patients who need more bone to place dental implants Enjoy living with INFUSE Bone Graft. www.medtronic.com Medtronic Spinal and Biologics Business Worldwide Headquarters

More information

Other treatments for chronic myeloid leukaemia

Other treatments for chronic myeloid leukaemia Other treatments for chronic myeloid leukaemia This information is an extract from the booklet Understanding chronic myeloid leukaemia. You may find the full booklet helpful. We can send you a copy free

More information

Docetaxel (Taxotere) This booklet explains what docetaxel is, when it may be prescribed, how it works and what side effects may occur.

Docetaxel (Taxotere) This booklet explains what docetaxel is, when it may be prescribed, how it works and what side effects may occur. Docetaxel (Taxotere) This booklet explains what docetaxel is, when it may be prescribed, how it works and what side effects may occur. Treatment Lorem ipsum and dolore side effects estes 2 Call our Helpline

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER PFIZER Dalacin C 150 mg Capsules clindamycin hydrochloride Dalacin C 150mg Capsules clindamycin hydrochloride PFIZER Read all of this leaflet carefully before

More information

For the Patient: Dasatinib Other names: SPRYCEL

For the Patient: Dasatinib Other names: SPRYCEL For the Patient: Dasatinib Other names: SPRYCEL Dasatinib (da sa' ti nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth. Tell your doctor if you have ever

More information

TC: Docetaxel and Cyclophosphamide

TC: Docetaxel and Cyclophosphamide PATIENT EDUCATION patienteducation.osumc.edu What is TC? It is the short name for the drugs used for this chemotherapy treatment. The two drugs you will receive during this treatment are Docetaxel (Taxotere

More information

1.3.1.3 PACKAGE LEAFLET

1.3.1.3 PACKAGE LEAFLET Sandoz Business use only Page 1 of 8 1.3.1.3 PACKAGE LEAFLET Sandoz Business use only Page 2 of 8 Package leaflet: Information for the patient Cefuhexal 250 mg film-coated tablets Cefuhexal 500 mg film-coated

More information

Disease modifying drug therapy

Disease modifying drug therapy Disease modifying drug therapy New edition for 2014-15 We hope you find the information in this book helpful. If you would like to speak with someone about any aspect of MS, contact the MS Trust information

More information

Rivaroxaban for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)

Rivaroxaban for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) Rivaroxaban for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) This leaflet aims to answer your questions about rivaroxaban that may be prescribed for you when you are diagnosed

More information

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets What is the most important information I should know about ELIQUIS? For people taking ELIQUIS for atrial fibrillation: People with atrial fibrillation

More information

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast Information for patients Pharmacy Your doctor has prescribed a tablet called rivaroxaban. This leaflet tells you about

More information

For the Patient: Paclitaxel injection Other names: TAXOL

For the Patient: Paclitaxel injection Other names: TAXOL For the Patient: Paclitaxel injection Other names: TAXOL Paclitaxel (pak'' li tax' el) is a drug that is used to treat many types of cancer. It is a clear liquid that is injected into a vein. Tell your

More information

Understanding How Existing and Emerging MS Therapies Work

Understanding How Existing and Emerging MS Therapies Work Understanding How Existing and Emerging MS Therapies Work This is a promising and hopeful time in the field of multiple sclerosis (MS). Many new and different therapies are nearing the final stages of

More information

You. guide to tuberculosis treatment and services

You. guide to tuberculosis treatment and services Adapted from TB and You: A Guide to Tuberculosis Treatment and Services with permission from Division of Public Health TB Control Program State of North Carolina Department of Health and Human Services

More information

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour. Shared Care Guideline for Prescription and monitoring of Naltrexone Hydrochloride in alcohol dependence Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist,

More information

2 What you need to know before you have Ampiclox

2 What you need to know before you have Ampiclox Reason for update: GDS 14 & QRD Updates Response to questions for variation update section 4.1 of SPC MHRA Submission Date: 6 November 2014 MHRA Approval Date: Text Date: October 2014 Text Issue and Draft

More information

CHOP Chemotherapy Regimen for Lymphoma Information for Patients

CHOP Chemotherapy Regimen for Lymphoma Information for Patients CHOP Chemotherapy Regimen for Lymphoma Information for Patients The Regimen Contains: C: Cytoxan (cyclophosphamide) H: Adriamycin (hydroxy doxorubicin) O: vincristine (Oncovin ) P: Prednisone How Is This

More information

Relapsing remitting MS

Relapsing remitting MS An introduction to Relapsing remitting MS What does it mean when you are diagnosed with relapsing remitting MS? There are three main types of MS: relapsing remitting MS, primary progressive MS and secondary

More information

Information about medicines for multiple sclerosis

Information about medicines for multiple sclerosis Information about medicines for multiple sclerosis Information about medicines for multiple sclerosis What is multiple sclerosis? 1 Multiple sclerosis (MS) is a lifelong disease that affects your brain

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Alvesco 40, 80 and 160 mcg Inhaler Ciclesonide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Alvesco 40, 80 and 160 mcg Inhaler Ciclesonide PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER Alvesco 40, 80 and 160 mcg Inhaler Ciclesonide Read all of this leaflet carefully before you start using this medicine because it contains important

More information

How long will it take to work? You may begin to feel better within a few days or it may take up to six weeks after your first treatment session.

How long will it take to work? You may begin to feel better within a few days or it may take up to six weeks after your first treatment session. Crohn's and Colitis UK Drug Treatment Information Improving life for people affected by inflammatory bowel diseases Infliximab This information leaflet aims to answer common questions you may have if you

More information

Severe rheumatoid arthritis (a disease that causes inflammation of the joints),where MabThera is given intravenously together with methotrexate.

Severe rheumatoid arthritis (a disease that causes inflammation of the joints),where MabThera is given intravenously together with methotrexate. EMA/614203/2010 EMEA/H/C/000165 EPAR summary for the public rituximab This is a summary of the European public assessment report (EPAR) for. It explains how the Committee for Medicinal Products for Human

More information

FEC chemotherapy. The drugs that are used. How treatment is given

FEC chemotherapy. The drugs that are used. How treatment is given Macmillan and Cancerbackup have merged. Together we provide free, high quality information for all. FEC chemotherapy This fact sheet is about a chemotherapy treatment for breast cancer called FEC. It describes

More information

Treatment for pleural mesothelioma

Treatment for pleural mesothelioma Treatment for pleural mesothelioma This information is an extract from the booklet Understanding mesothelioma. You may find the full booklet helpful. We can send you a free copy see page 9. Contents Treatment

More information

Shared Care Guideline for the use of Leflunomide for Rheumatoid Arthritis

Shared Care Guideline for the use of Leflunomide for Rheumatoid Arthritis Shared Care Guideline for the use of Leflunomide for Rheumatoid Section 1: Agreement for transfer of prescribing to GP Please sign this form and return it to the named consultant if you are willing to

More information

In non-hodgkin s lymphoma, MabThera is used to treat two types of the disease, both of which affect B-lymphocytes:

In non-hodgkin s lymphoma, MabThera is used to treat two types of the disease, both of which affect B-lymphocytes: EMA/614203/2010 EMEA/H/C/000165 EPAR summary for the public rituximab This is a summary of the European public assessment report (EPAR) for. It explains how the Committee for Medicinal Products for Human

More information

There is a risk of renal impairment in dehydrated children and adolescents.

There is a risk of renal impairment in dehydrated children and adolescents. PACKAGE LEAFLET: INFORMATION FOR THE USER MELFEN 200mg FILM-COATED TABLETS MELFEN 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking this medicine because it

More information

Information About Medicines for Multiple Sclerosis

Information About Medicines for Multiple Sclerosis Information About Medicines for Multiple Sclerosis Information About Medicines for Multiple Sclerosis What is multiple sclerosis? 1 Multiple sclerosis (MS) is a lifelong disease that affects your brain

More information

TAKING THE NEXT STEP

TAKING THE NEXT STEP FOR ADULTS WITH MS TAKING THE NEXT STEP AMPYRA TREATMENT GUIDE walking better matters See the Patient Medication Guide below. About AMPYRA (dalfampridine) Extended release tablets How is AMPYRA different?

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr NUCALA [new-ka la] mepolizumab lyophilized powder for subcutaneous injection Read this carefully before you start

More information